Allos (ALTH) Drops 16%+ as $2.20/Share Offer Withdrawn
Tweet
Share
E-mailGet Alerts ALTH Hot Sheet
Join SI Premium – FREE
Allos Therapeutics (Nasdaq: ALTH) is dipping today, following a broken buyout offer of $2.20 from an undisclosed publicly-traded pharmaceutical company.
Shares are down 16 percent on the session.
Click here for more from that report.
Shares are down 16 percent on the session.
Click here for more from that report.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Holcim said to acquire part of James Hardie's EU business
- Virtu Financial said to explore $3.5B sales of brokerage unit
- SpaceX attempted to acquire AI coding startup Cognition - Bloomberg
Create E-mail Alert Related Categories
Insiders' Blog, Mergers and Acquisitions, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
